Login with ORCID

association

Full identifier: http://purl.org/np/RA-nbFy1ufL3ZrNO7emMpKETsWuLD2zH-B_H7BryEtjzA#association

Assigned to 1 class:

Minted in Nanopublication

 RA-nbFy1uf comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RA-nbFy1uf... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal)
(xsd:dateTime)
.
This is the identifier for this whole nanopublication. http://purl.org/np/RA-nbFy1uf... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RA-nbFy1uf... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW...
.
This is the identifier for this whole nanopublication. http://purl.org/np/RA-nbFy1uf... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC...
.

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"Paricalcitol injection is contraindicated in patients with: Hypercalcemia [see Warnings and Precautions ( 5.1 Vitamin D toxicity [see Warnings and Precautions ( 5.1 Known hypersensitivity to paricalcitol or any of the inactive ingredients in paricalcitol injection. Hypersensitivity adverse reactions have been reported [e.g., angioedema (including laryngeal edema) and urticaria] [see Adverse Reactions ( 6.2 Hypercalcemia ( 4 Vitamin D toxicity ( 4 Known hypersensitivity to paricalcitol or any inactive ingredient ( 4"
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T17:03:50.432Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)